277 (Januvia 100 mg)

Generic Name: sitagliptin

Pill imprint 277 has been identified as Januvia 100 mg.

Januvia is used in the treatment of diabetes, type 2 and belongs to the drug class dipeptidyl peptidase 4 inhibitors. There is no proven risk in humans during pregnancy. Januvia 100 mg is not subject to the Controlled Substances Act.

See also related documents.

Imprint Search

Images for 277

Januvia 100 mg 277
Januvia 100 mg 277  Front
Januvia 100 mg 277  Back
Januvia 100 mg 277
Januvia
Generic Name:
sitagliptin
Imprint:
277
Strength:
100 mg
Color:
Brown
Size:
10.00 mm
Shape:
Round
Availability:
Prescription only
Drug Class:
Dipeptidyl peptidase 4 inhibitors
Pregnancy Category:
B - No proven risk in humans
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Merck & Company Inc.
National Drug Code (NDC):
00006-0277
Inactive Ingredients:
calcium phosphate dibasic anhydrous
croscarmellose sodium
magnesium stearate
microcrystalline cellulose
polyethylene glycol
polyvinyl alcohol
ferric oxide red
sodium stearyl fumarate
magnesium silicate
titanium dioxide
ferric oxide yellow
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
54569-5925 A S Medication Solutions LLC (repackager)
54868-5840 Physicians Total Care Inc (repackager)
35356-0103 Lake Erie Medical and Surgical Supply (repackager)

Note: Inactive ingredients may vary.

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide
(web5)